Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B1 | P14061 | 2/20 | 0.43 |
| ▸ | HSD17B2 | P37059 | 2/20 | 0.43 |
| ▸ | MTNR1A | P48039 | 4/20 | 0.41 |
| ▸ | MTNR1B | P49286 | 4/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | CETP | P11597 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26222015 | 0.89 | HSD17B1 (0.41) | HSD17B1HSD17B2MTNR1AMTNR1BNPC1 | |
| SCHEMBL26217412 | 0.83 | BCL2A1 (0.47) | HSD17B1HSD17B2MAPTTP53POLB | |
| SCHEMBL26217384 | 0.82 | LMNA (0.51) | MTNR1AMTNR1BNPC1RAB9AMAPT | |
| SCHEMBL26217468 | 0.82 | ALDH1A1 (0.47) | NPC1RAB9AMAPTTP53POLB | |
| SCHEMBL26217430 | 0.78 | CETP (0.43) | MAPTTP53POLBCETPLMNA | |
| SCHEMBL26217555 | 0.78 | L3MBTL1 (0.48) | RAB9AMAPTLMNAMEN1ALDH1A1 | |
| SCHEMBL26221117 | 0.76 | POLQ (0.45) | NPC1RAB9AMAPTTP53POLB | |
| SCHEMBL26217594 | 0.76 | ALDH1A1 (0.46) | NPC1RAB9AMAPTTP53POLB | |
| SCHEMBL26217450 | 0.73 | LMNA (0.45) | NPC1RAB9AMAPTTP53POLB | |
| SCHEMBL26217487 | 0.73 | LMNA (0.45) | NPC1RAB9AMAPTTP53POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230399292-A1 | ANESTHETIC COMPOUNDS AND METHODS OF MAKING AND USING SAME TO TREAT OR PREVENT PAIN SYMPTOMS | PTC Innovations, LLC | 2023-12-14 | — | — | US | disclosed |
| US-20230399291-A1 | ANESTHETIC COMPOUNDS AND METHODS OF MAKING AND USING SAME TO TREAT OR PREVENT PAIN SYMPTOMS | PTC INNOVATIONS LLC (US) | 2023-12-14 | — | — | US | disclosed |
| US-20230399290-A1 | ANESTHETIC COMPOUNDS AND METHODS OF MAKING AND USING SAME TO TREAT OR PREVENT PAIN SYMPTOMS | PTC INNOVATIONS LLC (US) | 2023-12-14 | — | — | US | disclosed |
| US-20230373906-A1 | ANESTHETIC COMPOUNDS AND METHODS OF MAKING AND USING SAME TO TREAT OR PREVENT PAIN SYMPTOMS | PTC INNOVATIONS LLC (US) | 2023-11-23 | — | — | US | disclosed |
| US-11814335-B1 | Anesthetic compounds and methods of making and using same to treat or prevent pain symptoms | PTC Innovations, LLC (US) | 2023-11-14 | — | — | US | disclosed |
| US-11786493-B2 | Anesthetic compounds and methods of making and using same to treat or prevent pain symptoms | PTC Innovations, LLC (US) | 2023-10-17 | — | — | US | disclosed |
| WO-2023172603-A1 | ANESTHETIC COMPOUNDS AND METHODS OF MAKING AND USING SAME TO TREAT OR PREVENT PAIN SYMPTOMS | PTC Innovations, LLC (US) | 2023-09-14 | — | — | WO | disclosed |
| US-20230286905-A1 | ANESTHETIC COMPOUNDS AND METHODS OF MAKING AND USING SAME TO TREAT OR PREVENT PAIN SYMPTOMS | PTC Innovations, LLC | 2023-09-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230399290-A1 | ANESTHETIC COMPOUNDS AND METHODS OF MAKING AND USING SAME TO TREAT OR PREVENT PAIN SYMPTOMS | OPRK1, ACHE, F5 | HSD17B1 1645/4885HSD17B2 1193/4885MTNR1A 1840/4885 |
| US-20230399292-A1 | ANESTHETIC COMPOUNDS AND METHODS OF MAKING AND USING SAME TO TREAT OR PREVENT PAIN SYMPTOMS | OPRM1, OPRL1, OPRK1 | HSD17B1 2498/4885HSD17B2 2269/4885MTNR1A 40/4885 |
| US-20230399291-A1 | ANESTHETIC COMPOUNDS AND METHODS OF MAKING AND USING SAME TO TREAT OR PREVENT PAIN SYMPTOMS | CHRM2, RXFP2, OPRM1 | HSD17B1 3392/4885HSD17B2 2028/4885MTNR1A 242/4885 |
| US-11814335-B1 | Anesthetic compounds and methods of making and using same to treat or prevent pain symptoms | F8, F5, OPRM1 | HSD17B1 1484/4885HSD17B2 1078/4885MTNR1A 1935/4885 |
| US-20230286905-A1 | ANESTHETIC COMPOUNDS AND METHODS OF MAKING AND USING SAME TO TREAT OR PREVENT PAIN SYMPTOMS | OPRM1, OPRL1, OPRK1 | HSD17B1 1401/4885HSD17B2 1434/4885MTNR1A 55/4885 |
| US-20230373906-A1 | ANESTHETIC COMPOUNDS AND METHODS OF MAKING AND USING SAME TO TREAT OR PREVENT PAIN SYMPTOMS | F5, EIF4G2, ACHE | HSD17B1 1272/4885HSD17B2 857/4885MTNR1A 1187/4885 |
| US-11786493-B2 | Anesthetic compounds and methods of making and using same to treat or prevent pain symptoms | OPRM1, OPRL1, OPRK1 | HSD17B1 1401/4885HSD17B2 1434/4885MTNR1A 55/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.